MedTrace Logo

The Efficacy and Safety of CARTO 3D Mapping System Versus Conventional Method in AF and VT

NCT00959205 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2010-05-20

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of electroanatomic imaging compared to conventional method in patients with VT.

Conditions

Interventions

DEVICE

CARTO 3D

CARTO (3D Electroanatomic imaging)

DEVICE

Angiography

Conventional fluoroscopically guided activation mapping

Sponsors & Collaborators

  • Korea University

    lead OTHER

Principal Investigators

  • Kim Young-Hoon, MD, PhD · Korea medical center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2010-06-30
Completion
2011-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00959205 on ClinicalTrials.gov